Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 2, 1999

View Archived Issues

Bavarian Nordic Research Institute interim report January-June 1999

1999 half-year highlights at Active Biotech

Positive results for Symlin in phase III study in type II diabetes

Japan Tobacco and Torii to form tie-up in R&D

Antrin photoangioplasty safe and clinically active in PAD therapy

Medarex and Gilead enter agreement concerning anti-CTLA-4 rights

Millennium extends CNS collaboration with Wyeth-Ayerst

Discovery Therapeutics initiates phase I studies of new cardiac treatment

Pharmacia & Upjohn completes acquisition of Sugen

Preparation, activity and use of piperidine protein farnesyltransferase inhibitors from LG Chemical

International patent covers Darwin Discovery's new PDE4/TNF inhibitors

Cytoclonal makes strides in the design of new anticancer compounds

CRF antagonists in development at Novartis

New Roche compounds enhance tumor delivery of 5-FU

Stanford team develops effective method for topical genetic immunization

Chemokine receptor modulators designed at Merck & Co.

Hydrazone derivatives from Novo Nordisk useful for normalizing glucose levels

Research at St. Charles Pharmaceuticals discussed at ACS

CombiChem presents design and synthesis of selective D4 ligands at ACS meeting

Glaxo Wellcome selects anti-HCMV compound GW-275175X for further study

Inhibitors of MMPs based on D-penicillamine presented by Agouron at ACS meeting

IGT-13, a new and improved etoposide analogue enters the IGT pipeline

More ACS news: preclinical profile of a novel protein farnesyltransferase inhibitor, Sch-207758

Novel antifungal agents targeting fungal prolyl-tRNA synthetase

Potential antiparkinsonian agent emerges from series of subtype-selective NMDA receptor antagonists

Dose-dependent cardioprotective effects of postocclusion ebselen in rabbit model

Ribi's synthetic glycolipid affords sustained cardioprotection in canine infarct model

Avant's sCR1 compounds effective in protecting myocardium in rat model of ischemia-reperfusion

New phenylethanolamine bronchodilators synthesized at Chinese university

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...